Sidoti analyst Anthony Lebiedzinski downgraded Prestige Consumer (PBH) to Neutral from Buy with a $90 price target The firm sees limited upside with the shares nearing the price target Further multiple expansion for Prestige may potentially be more limited, the analyst tells investors in a research note.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PBH:
- Prestige Consumer price target raised to $93 from $86 at Canaccord
- Prestige Consumer Healthcare Reports Robust Q2 FY25 Results
- Prestige Consumer Healthcare Exceeds Q2 2025 Expectations
- Prestige Consumer reports Q2 EPS $1.09, consensus $1.08
- Prestige Consumer backs FY25 adjusted EPS view $4.40-$4.46, consensus $4.74